戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 an unusual complication after placement of a transjugular intrahepatic portosystemic shunt.
2 ypertension undergoing elective placement of transjugular intrahepatic portosystemic shunts.
3 ith the advent of variceal band ligation and transjugular intrahepatic portosystemic shunt, almost ev
4 rum sodium<134 mEq/L, status-1, previous LT, transjugular intrahepatic portosystemic shunt, and acute
5                                              Transjugular intrahepatic portosystemic shunts are frequ
6 nts are associated with decreased patency at transjugular intrahepatic portosystemic shunt creation.
7                                              Transjugular intrahepatic portosystemic shunt has become
8  magnetic resonance imaging and placement of transjugular intrahepatic portosystemic shunts, have imp
9 may benefit from invasive modalities such as transjugular intrahepatic portosystemic shunting, hemodi
10 als comparing large-volume paracentesis with transjugular intrahepatic portosystemic shunt in the man
11                                            A transjugular intrahepatic portosystemic shunt is indicat
12                                              Transjugular intrahepatic portosystemic shunts may be he
13                                        Early transjugular intrahepatic portosystemic shunts placed in
14 on of preoperative portal vein embolization, transjugular intrahepatic portosystemic shunt placement,
15                                          The transjugular intrahepatic portosystemic shunt procedure
16 ased on data from patients who underwent the transjugular intrahepatic portosystemic shunt procedure.
17                                   A modified transjugular intrahepatic portosystemic shunt puncture s
18 Rarely, resistant cases have been treated by transjugular intrahepatic portosystemic shunt, surgical
19                                              Transjugular intrahepatic portosystemic shunt (TIPS) and
20 ed to evaluate the feasibility and safety of transjugular intrahepatic portosystemic shunt (TIPS) as
21 iction and diuretics, with thoracentesis and transjugular intrahepatic portosystemic shunt (TIPS) as
22 ient (PPG) to <12 mm Hg after placement of a transjugular intrahepatic portosystemic shunt (TIPS) cor
23 c factors of early liver failure (ELF) after transjugular intrahepatic portosystemic shunt (TIPS) cre
24 To compare the efficacy and complications of transjugular intrahepatic portosystemic shunt (TIPS) cre
25 8 mm Fluency covered stent and bare stent in transjugular intrahepatic portosystemic shunt (TIPS) for
26                   We describe the results of transjugular intrahepatic portosystemic shunt (TIPS) for
27 89 of the first procedure on human patients, transjugular intrahepatic portosystemic shunt (TIPS) has
28                                    Recently, transjugular intrahepatic portosystemic shunt (TIPS) has
29          Sepsis following the placement of a transjugular intrahepatic portosystemic shunt (TIPS) has
30 ing, studies show that patients treated with transjugular intrahepatic portosystemic shunt (TIPS) hav
31                                              Transjugular intrahepatic portosystemic shunt (TIPS) in
32 m safety, technical success, and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) in
33                   The efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) in
34                                              Transjugular intrahepatic portosystemic shunt (TIPS) is
35                                              Transjugular intrahepatic portosystemic shunt (TIPS) is
36                                          The transjugular intrahepatic portosystemic shunt (TIPS) is
37 doscopic therapy, liver transplantation, and transjugular intrahepatic portosystemic shunt (TIPS) on
38                               The effects of transjugular intrahepatic portosystemic shunt (TIPS) on
39 study was to test the safety and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) per
40 oring of hepatic blood flow before and after transjugular intrahepatic portosystemic shunt (TIPS) pla
41                                              Transjugular intrahepatic portosystemic shunt (TIPS) pla
42 tation for end stage liver disease underwent transjugular intrahepatic portosystemic shunt (TIPS) pla
43 estimate survival of patients undergoing the transjugular intrahepatic portosystemic shunt (TIPS) pro
44 e the incidence and complications related to transjugular intrahepatic portosystemic shunt (TIPS) ste
45 erated, we developed PV recanalization (PVR)-transjugular intrahepatic portosystemic shunt (TIPS) to
46 nstrate the feasibility of converting failed transjugular intrahepatic portosystemic shunt (TIPS) to
47                                   Additional transjugular intrahepatic portosystemic shunt (TIPS) was
48                                          The transjugular intrahepatic portosystemic shunt (TIPS) was
49    Limited data are available on the role of transjugular intrahepatic portosystemic shunt (TIPS) wit
50 hrombosis (PVT) has been mainly treated with transjugular intrahepatic portosystemic shunt (TIPS).
51 designed and commonly used for creation of a transjugular intrahepatic portosystemic shunt (TIPS).
52 pients had a prior transplant and five had a transjugular intrahepatic portosystemic shunt (TIPS).
53 d inpatient mortality in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS).
54 [repeated thoracentesis or paracentesis, and transjugular intrahepatic portosystemic shunt (TIPS)], b
55 g anticoagulation, angioplasty/thrombolysis, transjugular intrahepatic portosystemic shunting (TIPS),
56                                              Transjugular intrahepatic portosystemic shunts (TIPS) ar
57                                              Transjugular intrahepatic portosystemic shunts (TIPS) ar
58         Hyperbilirubinemia after creation of transjugular intrahepatic portosystemic shunts (TIPS) ha
59  of and the clinical picture of infection of transjugular intrahepatic portosystemic shunts (TIPS) ha
60                                              Transjugular intrahepatic portosystemic shunts (TIPS) ha
61 s indicate promising results with the use of transjugular intrahepatic portosystemic shunts (TIPS) in
62                                              Transjugular intrahepatic portosystemic shunts (TIPS) is
63 (PHG) and gastric vascular ectasia (GVE), to transjugular intrahepatic portosystemic shunts (TIPS) is
64                                              Transjugular intrahepatic portosystemic shunts (TIPS) lo
65                                              Transjugular intrahepatic portosystemic shunts (TIPS) ma
66 MS: There is controversy over the ability of transjugular intrahepatic portosystemic shunts (TIPS) to
67     There is controversy over the ability of transjugular intrahepatic portosystemic shunts (TIPS) to
68                      The clinical utility of transjugular intrahepatic portosystemic shunts (TIPS) vi
69 stic computed tomographic (CT) angiograms of transjugular intrahepatic portosystemic shunts (TIPS), h
70 ltrasonography in determining the patency of transjugular intrahepatic portosystemic shunts (TIPS).
71  in which a patient with a previously placed transjugular intrahepatic portosystemic shunt underwent
72 ts with small varices, a randomized trial of transjugular intrahepatic portosystemic shunt using cove
73                                            A transjugular intrahepatic portosystemic shunt was create

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。